MHRA data strategy: Overview and collaboration at UK and global level

3.30pm – 3.50pm GMT, 6 November 2024 ‐ 20 mins

Presentation

Session Three: Data, digital technologies and real-world evidence

Session Chair: Kathy Williams, Head of Global Regulatory Policy and Intelligence, AstraZeneca, and Vice-Chair, BIA Regulatory Affairs Advisory Committee